Company news
TheraCryf PLC news in 2017
TheraCryf PLC's news releases, calls and decks from 2017, newest first.
Collaboration with King's College London
December 13, 2017
Hardman Res.: Funded to the end of Phase II trials
December 11, 2017
First European Patent Grant
October 4, 2017
SFX-01 data published in Peer Reviewed Journal
August 2, 2017
Charity-funded Study of SFX-01 in TNBC
July 11, 2017
Hardman Research: Making clinical progress
June 21, 2017
Compassionate Use Programme and Trials Update
June 1, 2017
Notice of Preliminary Results
May 25, 2017
Further US Patent Grant
March 28, 2017
Issue of Equity, PDMR Shareholding and TVR
March 6, 2017
Patent Grant in the United States
February 14, 2017
Services Agreement with APTrans
February 13, 2017
First Patient Dosed in Breast Cancer Trial
January 17, 2017
Positive DSMB Review of SAS Trial
January 11, 2017